ARCHIVES

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

May 18, 2007

White House Gives FDA Authority Over Tobacco Product Sales

August 18, 1995

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

November 21, 2014

White House Yet To Name NCAB, Cancer Panel Members

February 11, 2011

HHS Plan Ties Breast Screening; Mammography Quality

July 16, 1993

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993